✦ LIBER ✦

Tolerance and activity of oxaliplatin with protracted topotecan infusion in patients with previously treated ovarian cancer. A phase I study

✍ Scribed by Howard Hochster; Thomas T. Chen; Janice M. Lu; Day Hills; Joan Sorich; Juliet Escalon; Percy Ivy; Leonard Liebes; Franco Muggia

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Phase I Study of Weekly Topotecan and

✍ H. Homesley; B. Benigno; J. Williams; L. Vaccarello 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Extended phase II study of paclitaxel as

✍ A. du Bois; H.J. Lück; K. Buser; H.G. Meerpohl; C. Sessa; U. Klaassen; H. Meden; 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 693 KB

A phase I study of exisulind in previous

✍ Kelly, K; Mikhaeel, N; Dempsey, E; Magree, L; Bunn, P.A 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 108 KB

A phase II study of sequential carboplat

✍ Guppy, A E; Nelstrop, A E; Foster, T; Agarwal, R; Seckl, M J; Rustin, G J S 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 99 KB

A phase I trial of gemcitabine and topot

✍ M. Dwight Chen; Gini F. Fleming; Suann Mitchell; Ira Horowitz 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 95 KB

A phase II study of oxaliplatin, docetax

✍ Frederick Locke; Joseph I. Clark; Thomas F. Gajewski 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 268 KB